Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Evome Medical Technologies Inc V.EVMT

Alternate Symbol(s):  LNDZF

Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. It offers concussion, fall screening and balance assessment and training programs.


TSXV:EVMT - Post by User

Post by MBAon Jan 27, 2016 7:34am
177 Views
Post# 24497180

Roll Back - Good Strategic Move

Roll Back - Good Strategic MoveIn my opinion, this is a good business decision. Business in early stages and needs to prove its business plan will work. So far, looks like some traction but not as rosy as Dalsin promoted. Overall the company made good progress in less than a year. As for the roll back, I believe it is good on two fronts: 1) need to do in order for the company to get additional financing. this is needed to grow the company. A finance company can only grow so much on $22 million. 2) who wants to own a 7-10 cent stock. A lot of negative feelings with a "real" penny stock, even with retail investors. Aside from the bad historical track record with consolidation, there is also the negative feeling of having odd lot share amounts. I expect some selling cause of the latter but overall I prefer owning a 70 - 90 cent stock much better than a 7-9 cent stock. Valuation is the same and most investors understand that. Predict a 75 cent close today
Bullboard Posts